Pharmacogenomics, Regulation and Signaling Pathways of Phase I and II Drug Metabolizing Enzymes

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|3|5|481-490

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.3, Iss.5, 2002-10, pp. : 481-490

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cancer and Phase II Drug-Metabolizing Enzymes

By  

Current Drug Metabolism, Vol. 4, Iss. 1, 2003-02 ,pp. : 45-58

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Phase II Drug Metabolizing Enzymes in Cancer Chemoprevention

By  

Current Drug Metabolism, Vol. 10, Iss. 6, 2009-07 ,pp. : 595-616

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenomics in Drug-Metabolizing Enzymes Catalyzing Anticancer Drugs for Personalized Cancer Chemotherapy

By  

Current Drug Metabolism, Vol. 8, Iss. 6, 2007-08 ,pp. : 554-562

Bentham Science Publishers

Access to resources Recommend Favorite

Schistosoma mansoni Changes the Activity of Phase II Drug-Metabolizing Enzymes: Role of Praziquantel as Antibilharzial Drug

By  

Drug Metabolism Letters, Vol. 4, Iss. 3, 2010-01 ,pp. : 134-138

Bentham Science Publishers

Access to resources Recommend Favorite

Regulation of drug-metabolizing cytochrome P450 enzymes by glucocorticoids

By Dvorak Zdenek   Pavek Peotr  

Drug Metabolism Reviews, Vol. 42, Iss. 4, 2010-11 ,pp. : 621-635

Informa Healthcare

Access to resources Recommend Favorite